Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition … S Loi, N Sirtaine, F Piette, R Salgado, G Viale, F Van Eenoo, G Rouas, ... J Clin Oncol 31 (7), 860-867, 2013 | 1178 | 2013 |
Prediction of cancer outcome with microarrays: a multiple random validation strategy S Michiels, S Koscielny, C Hill The Lancet 365 (9458), 488-492, 2005 | 1153 | 2005 |
Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women … P McGale, C Taylor, C Correa, D Cutter, F Duane, M Ewertz, R Gray, ... Lancet (London, England) 383 (9935), 2014 | 1105 | 2014 |
Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial S Loi, S Michiels, R Salgado, N Sirtaine, V Jose, D Fumagalli, ... Annals of oncology 25 (8), 1544-1550, 2014 | 916 | 2014 |
Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis. X Paoletti, K Oba, T Burzykowski, S Michiels, Y Ohashi, JP Pignon, ... Jama 303 (17), 1729-1737, 2010 | 790 | 2010 |
Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials. RG M Dowsett, J F Forbes, R Bradley, J Ingle, T Aihara, J Bliss, F Boccardo ... Lancet 386 (10001), 1341-1352, 2015 | 687* | 2015 |
Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data FC Bidard, DJ Peeters, T Fehm, F Nolé, R Gisbert-Criado, D Mavroudis, ... The lancet oncology 15 (4), 406-414, 2014 | 652 | 2014 |
CD4+ follicular helper T cell infiltration predicts breast cancer survival C Gu-Trantien, S Loi, S Garaud, C Equeter, M Libin, A De Wind, M Ravoet, ... The Journal of clinical investigation 123 (7), 2873-2892, 2013 | 581 | 2013 |
Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: an updated meta-analysis. P Thirion, S Michiels, JP Pignon, M Buyse, AC Braud, RW Carlson, ... Journal of clinical oncology: official journal of the American Society of …, 2004 | 558* | 2004 |
Gene expression profiling of primary cutaneous melanoma and clinical outcome V Winnepenninckx, V Lazar, S Michiels, P Dessen, M Stas, SR Alonso, ... Journal of the National Cancer Institute 98 (7), 472-482, 2006 | 532* | 2006 |
False discovery rate, sensitivity and sample size for microarray studies Y Pawitan, S Michiels, S Koscielny, A Gusnanto, A Ploner Bioinformatics 21 (13), 3017-3024, 2005 | 517 | 2005 |
Benefits of adding a drug to a single-agent or a 2-agent chemotherapy regimen in advanced non–small-cell lung cancer: a meta-analysis C Delbaldo, S Michiels, N Syz, JC Soria, T Le Chevalier, JP Pignon Jama 292 (4), 470-484, 2004 | 457 | 2004 |
Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis The Lancet. Oncology 16 (6), 645-655, 2015 | 449 | 2015 |
Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials. RG R Coleman, T Powles, A Paterson, M Gnant, S Anderson, I Diel, J Gralow, G ... Lancet 386 (10001), 1353-1361, 2015 | 415* | 2015 |
Tumor-infiltrating lymphocytes and associations with pathological complete response and event-free survival in HER2-positive early-stage breast cancer treated with lapatinib … R Salgado, C Denkert, C Campbell, P Savas, P Nuciforo, C Aura, ... JAMA oncology 1 (4), 448-455, 2015 | 358 | 2015 |
Progression-free survival is a surrogate for survival in advanced colorectal cancer M Buyse, T Burzykowski, K Carroll, S Michiels, DJ Sargent, LL Miller, ... Journal of clinical oncology 25 (33), 5218-5224, 2007 | 357 | 2007 |
High-throughput genomics and clinical outcome in hard-to-treat advanced cancers: results of the MOSCATO 01 trial C Massard, S Michiels, C Ferté, MC Le Deley, L Lacroix, A Hollebecque, ... Cancer discovery 7 (6), 586-595, 2017 | 335 | 2017 |
Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array F Andre, B Job, P Dessen, A Tordai, S Michiels, C Liedtke, C Richon, ... Clinical cancer research 15 (2), 441-451, 2009 | 330 | 2009 |
Molecular subclasses of breast cancer: how do we define them? The IMPAKT 2012 Working Group Statement S Guiu, S Michiels, F André, J Cortes, C Denkert, A Di Leo, BT Hennessy, ... Annals of oncology 23 (12), 2997-3006, 2012 | 303 | 2012 |
Elucidating prognosis and biology of breast cancer arising in young women using gene expression profiling HA Azim, S Michiels, PL Bedard, SK Singhal, C Criscitiello, M Ignatiadis, ... Clinical cancer research 18 (5), 1341-1351, 2012 | 291 | 2012 |